{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T23:52:31Z","timestamp":1777852351645,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82325008"],"award-info":[{"award-number":["82325008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70729-0","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:56:29Z","timestamp":1773413789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatocyte SLCO4C1 is a cAMP uptake transporter for inhibiting lipogenesis and a therapeutic target for MASLD"],"prefix":"10.1038","volume":"17","author":[{"given":"Xiaojia","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changpei","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huayu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingdong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9027-7307","authenticated-orcid":false,"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoman","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangchuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3650-1507","authenticated-orcid":false,"given":"Mindian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-2631","authenticated-orcid":false,"given":"Minghua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6322-7753","authenticated-orcid":false,"given":"Christopher D.","family":"Byme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-3900","authenticated-orcid":false,"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3423-0042","authenticated-orcid":false,"given":"Xinshou","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1033-3098","authenticated-orcid":false,"given":"Qiong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2116-0233","authenticated-orcid":false,"given":"Chuanzheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaizheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8543-4566","authenticated-orcid":false,"given":"Jin","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"70729_CR1","doi-asserted-by":"crossref","unstructured":"Gan, C. et al. Liver diseases: epidemiology, causes, trends and predictions. Signal Transduct Target Ther. 10, 33 (2025).","DOI":"10.1038\/s41392-024-02072-z"},{"key":"70729_CR2","doi-asserted-by":"crossref","unstructured":"Eslam M, George J. Two years on, a perspective on MAFLD. eGastroenterology 1, e100019 (2023).","DOI":"10.1136\/egastro-2023-100019"},{"key":"70729_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jhep.2024.05.014","volume":"81","author":"JH Gao","year":"2024","unstructured":"Gao, J. H. et al. Angiocrine signaling in sinusoidal homeostasis and liver diseases. J. Hepatol. 81, 543\u2013561 (2024).","journal-title":"J. Hepatol."},{"key":"70729_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison, S. A. et al. A Phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N. Engl. J. Med. 390, 497\u2013509 (2024).","journal-title":"N. Engl. J. Med."},{"key":"70729_CR5","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","volume":"384","author":"PN Newsome","year":"2021","unstructured":"Newsome, P. N. et al. A Placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N. Engl. J. Med. 384, 1113\u20131124 (2021).","journal-title":"N. Engl. J. Med."},{"key":"70729_CR6","doi-asserted-by":"crossref","unstructured":"Song, Y. et al. Vitamin E (300 mg) in the treatment of MASH: a multi-center, randomized, double-blind, placebo-controlled study. Cell Rep. Med. 6, 101939 (2025).","DOI":"10.1016\/j.xcrm.2025.101939"},{"key":"70729_CR7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jhep.2024.04.034","volume":"81","author":"SA Harrison","year":"2024","unstructured":"Harrison, S. A., Rolph, T., Knott, M. & Dubourg, J. FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond. J. Hepatol. 81, 562\u2013576 (2024).","journal-title":"J. Hepatol."},{"key":"70729_CR8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cmet.2022.03.005","volume":"34","author":"S Katsumura","year":"2022","unstructured":"Katsumura, S. et al. Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure. Cell Metab. 34, 564\u2013580.e8 (2022).","journal-title":"Cell Metab."},{"key":"70729_CR9","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jhep.2025.02.003","volume":"83","author":"Z Liu","year":"2025","unstructured":"Liu, Z. et al. Protein phosphatase 6 regulates metabolic dysfunction-associatedsteatohepatitis via the mTORC1 pathway. J. Hepatol. 83, 630\u2013642 (2025).","journal-title":"J. Hepatol."},{"key":"70729_CR10","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S2468-1253(23)00272-8","volume":"8","author":"SA Harrison","year":"2023","unstructured":"Harrison, S. A. et al. Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial.  Lancet Gastroenterol. Hepatol. 8, 1080\u20131093 (2023).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"70729_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mdb2.70012","volume":"1","author":"X Zhao","year":"2025","unstructured":"Zhao, X. et al. Harnessing gut microbiome\u2013brain\u2013liver crosstalk: novel therapeutic strategies for metabolic dysfunction-associated steatotic liver disease. Med. Bull. 1, 136\u2013153 (2025).","journal-title":"Med. Bull."},{"key":"70729_CR12","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00726-020-02867-8","volume":"52","author":"E Taghikhani","year":"2020","unstructured":"Taghikhani, E. et al. Vectorial transport of the arginine derivatives asymmetric dimethylarginine (ADMA) andl-homoarginine by OATP4C1 and P-glycoprotein studied in double-transfected MDCK cells. Amino Acids 52, 975\u2013985 (2020).","journal-title":"Amino Acids"},{"key":"70729_CR13","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1073\/pnas.0304987101","volume":"101","author":"T Mikkaichi","year":"2004","unstructured":"Mikkaichi, T. et al. Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. Proc. Natl. Acad. Sci. USA 101, 3569\u20133574 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70729_CR14","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1002\/jps.22641","volume":"100","author":"T Suzuki","year":"2011","unstructured":"Suzuki, T. et al. Transcriptional regulation of organic anion transporting polypeptide SLCO4C1 as a New therapeutic modality to prevent chronic kidney disease. J. Pharm. Sci. 100, 3696\u20133707 (2011).","journal-title":"J. Pharm. Sci."},{"key":"70729_CR15","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1681\/ASN.2009070696","volume":"20","author":"T Toyohara","year":"2009","unstructured":"Toyohara, T. et al. SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation. J. Am. Soc. Nephrol. 20, 2546\u20132555 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"70729_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09735-4","volume":"10","author":"K Kikuchi","year":"2019","unstructured":"Kikuchi, K. et al. Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease. Nat. Commun. 10, 17 (2019).","journal-title":"Nat. Commun."},{"key":"70729_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1371\/journal.pgen.1006657","volume":"13","author":"C Serra-Juh\u00e9","year":"2017","unstructured":"Serra-Juh\u00e9, C. et al. Novel genes involved in severe early-onset obesity revealed by rare copy number and sequence variants. PLoS Genet 13, 19 (2017).","journal-title":"PLoS Genet"},{"key":"70729_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jep.2020.113453","volume":"266","author":"YH Jiang","year":"2021","unstructured":"Jiang, Y. H. et al. Banxia Baizhu Tianma decoction attenuates obesity-related hypertension. J. Ethnopharmacol. 266, 9 (2021).","journal-title":"J. Ethnopharmacol."},{"key":"70729_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-024-01524-x","volume":"17","author":"HY Zhang","year":"2024","unstructured":"Zhang, H. Y. et al. cAMP-PKA\/EPAC signaling and cancer: the interplay in tumor microenvironment. J. Hematol. Oncol. 17, 31 (2024).","journal-title":"J. Hematol. Oncol."},{"key":"70729_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fendo.2022.899731","volume":"13","author":"X Feng","year":"2022","unstructured":"Feng, X. et al. Parathyroid hormone alleviates non-alcoholic liver steatosis via activating the hepatic cAMP\/PKA\/CREB pathway. Front Endocrinol. 13, 10 (2022).","journal-title":"Front Endocrinol."},{"key":"70729_CR21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41392-022-01284-5","volume":"8","author":"YD Zhang","year":"2023","unstructured":"Zhang, Y. D. et al. 3-Hydroxybutyrate ameliorates insulin resistance by inhibiting PPAR\u03b3 Ser273 phosphorylation in type 2 diabetic mice. Signal Transduct. Target Ther. 8, 10 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"70729_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","volume":"12","author":"P Ferr\u00e9","year":"2010","unstructured":"Ferr\u00e9, P. & Foufelle, F. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diab Obes. Metab. 12, 83\u201392 (2010).","journal-title":"Diab Obes. Metab."},{"key":"70729_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.metabol.2024.155916","volume":"155","author":"HY Luo","year":"2024","unstructured":"Luo, H. Y. et al. Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice. Metab. -Clin. Exp. 155, 14 (2024).","journal-title":"Metab. -Clin. Exp."},{"key":"70729_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molmet.2024.101882","volume":"80","author":"JY Wang","year":"2024","unstructured":"Wang, J. Y. et al. Hepatic regulator of G protein signaling 14 ameliorates NAFLD through activating cAMP-AMPK signaling by targeting Gi\u03b11\/3. Mol. Metab. 80, 15 (2024).","journal-title":"Mol. Metab."},{"key":"70729_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fimmu.2022.880298","volume":"13","author":"YM Duan","year":"2022","unstructured":"Duan, Y. M. et al. Association of inflammatory cytokines with non-alcoholic fatty liver disease. Front Immunol. 13, 15 (2022).","journal-title":"Front Immunol."},{"key":"70729_CR26","first-page":"11","volume":"6","author":"K Kjaergaard","year":"2024","unstructured":"Kjaergaard, K. et al. Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation. JHEP Rep. 6, 11 (2024).","journal-title":"JHEP Rep."},{"key":"70729_CR27","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/ueg2.12534","volume":"12","author":"R Gallego-Dur\u00e1n","year":"2024","unstructured":"Gallego-Dur\u00e1n, R. et al. Fibroblast growth factor 21 is a hepatokine involved in MASLD progression. U. Eur. Gastroenterol. J. 12, 1056\u20131068 (2024).","journal-title":"U. Eur. Gastroenterol. J."},{"key":"70729_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.redox.2016.12.024","volume":"11","author":"MA G\u00f3mez-S\u00e1mano","year":"2017","unstructured":"G\u00f3mez-S\u00e1mano, M. A. et al. Fibroblast growth factor 21 and its novel association with oxidative stress. Redox Biol. 11, 335\u2013341 (2017).","journal-title":"Redox Biol."},{"key":"70729_CR29","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1073\/pnas.78.6.3363","volume":"78","author":"KB Seamon","year":"1981","unstructured":"Seamon, K. B., Padgett, W. & Daly, J. W. Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc. Natl. Acad. Sci. USA 78, 3363\u20133367 (1981).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70729_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pharmr.2024.100023","volume":"77","author":"B Hagenbuch","year":"2025","unstructured":"Hagenbuch, B., Stieger, B. & Locher, K. P. Organic anion transporting polypeptides: pharmacology, toxicology, structure, and transport mechanisms. Pharm. Rev. 77, 35 (2025).","journal-title":"Pharm. Rev."},{"key":"70729_CR31","first-page":"722","volume":"50","author":"M Lando","year":"1990","unstructured":"Lando, M., Abemayor, E., Anthony Verity, M. & Sidell, N. Modulation of intracellular cyclic adenosine monophosphate levels and the differentiation response of human neuroblastoma cells. Cancer Res. 50, 722\u2013727 (1990).","journal-title":"Cancer Res."},{"key":"70729_CR32","doi-asserted-by":"publisher","first-page":"e100005","DOI":"10.1136\/egastro-2023-100005","volume":"1","author":"J Zhou","year":"2023","unstructured":"Zhou, J. et al. Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis. eGastroenterology 1, e100005 (2023).","journal-title":"eGastroenterology"},{"key":"70729_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1371\/journal.pone.0066518","volume":"8","author":"Y Akiyama","year":"2013","unstructured":"Akiyama, Y. et al. Indoxyl sulfate down-regulates SLCO4C1 transporter through up-regulation of GATA3. PLoS One 8, 10 (2013).","journal-title":"PLoS One"},{"key":"70729_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1126\/scitranslmed.adh9940","volume":"16","author":"JJ Ding","year":"2024","unstructured":"Ding, J. J. et al. Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population. Sci. Transl. Med 16, 15 (2024).","journal-title":"Sci. Transl. Med"},{"key":"70729_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41588-025-02407-8","volume":"57","author":"ZY Li","year":"2025","unstructured":"Li, Z. Y. et al. Spatially resolved multi-omics of human metabolic dysfunction-associated steatotic liver disease. Nat. Genet 57, 32 (2025).","journal-title":"Nat. Genet"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70729-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70729-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70729-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:34:54Z","timestamp":1777502094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70729-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70729"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70729-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3916"}}